The safety of amphotericin B lipid complex in patients with prior severe intolerance to liposomal amphotericin B.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 23166189.
- Also identified by DOI 10.1093/cid/cis972.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The tolerability of amphotericin B lipid complex in patients with previous severe infusion reactions to liposomal amphotericin B is unclear. We reviewed the charts of 40 such patients at a tertiary care cancer center and found that amphotericin B lipid complex administration was uneventful in 34 patients (85% [95% confidence interval, 69%-93%]).
Medical subject headings
- Amphotericin B
- Antifungal Agents
- Neoplasms